NO832801L - Fremgangsmaate for fremstilling av beta-laktam-antibiotika - Google Patents

Fremgangsmaate for fremstilling av beta-laktam-antibiotika

Info

Publication number
NO832801L
NO832801L NO832801A NO832801A NO832801L NO 832801 L NO832801 L NO 832801L NO 832801 A NO832801 A NO 832801A NO 832801 A NO832801 A NO 832801A NO 832801 L NO832801 L NO 832801L
Authority
NO
Norway
Prior art keywords
amino
methyl
oxo
ester
oxy
Prior art date
Application number
NO832801A
Other languages
English (en)
Norwegian (no)
Inventor
Hermann Breuer
Henner Straub
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO832801L publication Critical patent/NO832801L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO832801A 1982-08-04 1983-08-03 Fremgangsmaate for fremstilling av beta-laktam-antibiotika NO832801L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40494582A 1982-08-04 1982-08-04

Publications (1)

Publication Number Publication Date
NO832801L true NO832801L (no) 1984-02-06

Family

ID=23601669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832801A NO832801L (no) 1982-08-04 1983-08-03 Fremgangsmaate for fremstilling av beta-laktam-antibiotika

Country Status (33)

Country Link
US (1) US4939253A (bg)
JP (1) JPS5993046A (bg)
KR (1) KR900001211B1 (bg)
AR (1) AR241158A1 (bg)
AT (1) AT382367B (bg)
AU (1) AU568086B2 (bg)
BE (1) BE897466A (bg)
CH (1) CH655309A5 (bg)
CS (4) CS26783A2 (bg)
DD (1) DD213919A5 (bg)
DE (1) DE3328047A1 (bg)
DK (1) DK354683A (bg)
ES (1) ES8502114A1 (bg)
FI (1) FI832675A (bg)
FR (1) FR2531427A1 (bg)
GB (1) GB2125794B (bg)
GR (1) GR79368B (bg)
HU (1) HU191058B (bg)
IE (1) IE55839B1 (bg)
IL (1) IL69381A (bg)
IN (1) IN160955B (bg)
IT (1) IT1224129B (bg)
LU (1) LU84947A1 (bg)
NL (1) NL8302746A (bg)
NO (1) NO832801L (bg)
NZ (1) NZ205111A (bg)
PL (3) PL243308A1 (bg)
PT (1) PT77155B (bg)
RO (1) RO86511B (bg)
SE (1) SE8304256L (bg)
SU (1) SU1329617A3 (bg)
YU (1) YU43324B (bg)
ZA (1) ZA835470B (bg)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
EP0127177B1 (en) * 1983-05-31 1988-12-21 E.R. Squibb & Sons, Inc. [[(3-Acylamino-2-oxo-1-azetidinyl)oxy]methyl]phosphinic acids
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4548751A (en) * 1983-08-03 1985-10-22 E. R. Squibb & Sons, Inc. (2-Oxo-1-azetidinyloxy)-2-propenoic acid
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
CA1243679A (en) * 1983-09-14 1988-10-25 Henner Straub 3-ACYLAMINO-2-OXO-1-AZETIDINYL-.beta.-OXYPROPIONATES
EP0135194A1 (en) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinones and their production
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
US4551277A (en) * 1983-11-09 1985-11-05 E. R. Squibb & Sons, Inc. 4-(3-Acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
EP1827449A4 (en) * 2004-11-17 2008-01-23 Smithkline Beecham Corp USE OF NOVEL ANTIBACTERIAL COMPOUNDS
PL1965798T3 (pl) * 2005-12-07 2012-02-29 Basilea Pharmaceutica Ag Użyteczne antybiotyki monobaktamowe
WO2014164526A1 (en) * 2013-03-13 2014-10-09 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205240A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Sulphonamide derivatives,being starting materials for producing beta-lactams
EP0048953B1 (en) * 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-lactam antibiotics
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs

Also Published As

Publication number Publication date
CS26785A2 (en) 1985-08-15
ES524698A0 (es) 1984-12-16
HU191058B (en) 1986-12-28
PT77155A (en) 1983-09-01
GR79368B (bg) 1984-10-22
LU84947A1 (fr) 1984-03-23
KR900001211B1 (ko) 1990-02-28
PL257440A1 (en) 1986-10-07
FI832675A (fi) 1984-02-05
ZA835470B (en) 1984-04-25
GB2125794B (en) 1985-12-18
IN160955B (bg) 1987-08-22
PL257441A1 (en) 1986-10-07
DK354683D0 (da) 1983-08-03
JPS5993046A (ja) 1984-05-29
IE55839B1 (en) 1991-01-30
YU43324B (en) 1989-06-30
SU1329617A3 (ru) 1987-08-07
CS26885A2 (en) 1985-08-31
SE8304256D0 (sv) 1983-08-03
ATA281283A (de) 1986-07-15
ES8502114A1 (es) 1984-12-16
AT382367B (de) 1987-02-25
CH655309A5 (fr) 1986-04-15
PL243308A1 (en) 1985-12-17
CS243499B2 (en) 1986-06-12
AU1755683A (en) 1984-02-09
US4939253A (en) 1990-07-03
GB2125794A (en) 1984-03-14
KR840005814A (ko) 1984-11-19
NL8302746A (nl) 1984-03-01
FR2531427A1 (fr) 1984-02-10
NZ205111A (en) 1986-06-11
IT1224129B (it) 1990-09-26
DD213919A5 (de) 1984-09-26
YU162783A (en) 1986-02-28
DE3328047A1 (de) 1984-02-09
CS575983A2 (en) 1985-08-15
FR2531427B1 (bg) 1985-04-19
SE8304256L (sv) 1984-02-05
RO86511A (ro) 1985-03-15
AR241158A2 (es) 1991-12-30
GB8320497D0 (en) 1983-09-01
IL69381A (en) 1987-07-31
IT8322430A0 (it) 1983-08-04
AU568086B2 (en) 1987-12-17
CS243498B2 (en) 1986-06-12
IE831830L (en) 1984-02-04
FI832675A0 (fi) 1983-07-22
CS243474B2 (en) 1986-06-12
PT77155B (en) 1986-01-28
IL69381A0 (en) 1983-11-30
BE897466A (fr) 1984-02-06
RO86511B (ro) 1985-03-31
DK354683A (da) 1984-02-05
AR241158A1 (es) 1991-12-30
CS26783A2 (en) 1985-08-31

Similar Documents

Publication Publication Date Title
NO832801L (no) Fremgangsmaate for fremstilling av beta-laktam-antibiotika
US4581170A (en) N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EP0051381B1 (en) O-sulfated beta-lactam hydroxamic acids
US4633017A (en) N-hydroxy protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EP0048953B1 (en) Beta-lactam antibiotics
US4670553A (en) 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
US4534896A (en) 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
NO830003L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-okso-1-(aminokarbonylaminosulfonylaminokarbonyl)azetidiner
US4533660A (en) Antibacterial O-sulfated β-lactam hydroxamic acids
US4723002A (en) 1-(substituted phosphorous)-azetidinone antibacterials
NO833626L (no) Fremgangsmaate for fremstilling av antibiotisk aktive beta-laktamer
US4548751A (en) (2-Oxo-1-azetidinyloxy)-2-propenoic acid
US4551277A (en) 4-(3-Acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid
US4681937A (en) 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
US4889930A (en) Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
FR2581062A1 (fr) Acides b-lactame hydroxamiques o-sulfates, a action therapeutique
US4670554A (en) ((3-Acylamino-2-oxo-1-azetidinyl)oxy)methyl)phosphinic acids
US4551276A (en) 2-Oxoazetidin-1-yloxymethyl sulfonic acid and analogs
US5106977A (en) Intermediates for a process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl]azetidines
US4980465A (en) Process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl)] azetidines and intermediates used therein
CA1268763A (en) 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
EP0135814A1 (en) 1-(1H-tetrazol-5-ylalkoxy)-2-azetidinones
HU186490B (en) Process for producing salts of 4-bracket-substituted mercapto-bracket closed-2-oxo-azetidine-sulfonic acid
FR2551750A1 (fr) 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique
EP0187355A1 (en) Process for preparing beta-lactam antibiotics